Therapeutic innovation has reshaped the dermatology landscape, expanding treatment options for chronic inflammatory dermatoses such as psoriasis, atopic dermatitis, vitiligo, chronic hand eczema, and hidradenitis suppurativa. Yet for many late-stage development programs, the central challenge is no longer whether a therapy can...
